Edgewise Therapeutics Completes $95 Million Series C Financing to Advance Clinical Development of Muscular Dystrophy Program

Edgewise Therapeutics, a clinical-stage biopharmaceutical company developing orally bioavailable, small molecule therapies for musculoskeletal diseases, today announced the closing of a $95 million Se...

Learn More

SomaLogic Closes $121M Series A Financing Led by Casdin Capital

SomaLogic, Inc., global leader in proteomic discovery and applications transforming biomedical discovery and clinical diagnostics, announced today that the Company has successfully closed an Initial S...

Learn More

$7.7 Million Advanced Industries Awards Fuel 37 Colorado Start-ups

Colorado Office of Economic Development and International Trade (OEDIT)’s Advanced Industries Accelerator Grant Program realeased a list of 37 Colorado start-ups approved for funding. A total of...

Learn More

Prima-Temp Awarded Groundbreaking Patent Using Artificial Intelligence For Ovulation Prediction

Prima-Temp, Inc., a leader in developing digital health solutions through chronobiology, has been awarded a patent recognizing its innovative approach to applying artificial intelligence (AI) to women...

Learn More

Boulder-based biotech SomaLogic has entered a five-year partnership with the Food & Drug Administration

It can be very difficult to manufacture generic versions of biologic drugs. But SomaLogic has a test that can help determine whether a new drug candidate is similar enough to the original drug to be c...

Learn More

L7 Informatics Automates Lab Operations and Supports Washington University School of Medicine with Workflow for Its Saliva-based COVID-19 Test

L7 Informatics announced that it has deployed L7 | ESP to automate all lab operations starting with COVID-related workflow at the Genome Technology Access Center (GTAC@MGI) in the McDonnell Genome Ins...

Learn More

To Support Go/No-Go Decisions in Early Drug Development, Inotiv Got It Together — Fast

Pharmaceutical and medical device companies are always under pressure to improve research productivity. Increasingly, they rely on contract research organizations (CROs) for access to specific experti...

Learn More

LightDeck Diagnostics Raises $11 Million Series B to Offer Five-Minute Affordable COVID-19 Tests, Taking the ‘Point-of-Care’ Anywhere

LightDeck Diagnostics today announced $11 million in Series B financing from Incubic, Entrada and Boulder Ventures. The funds will support the development and commercialization of in vitro multiplex t...

Learn More

Boulder biotech Biodesix CEO: Why timing was right for IPO

In an exclusive interview, CEO Scott Hutton talks about the next steps for the company, which specializes in blood-based diagnostic tests for lung diseases. Find out more in the Denver Business Journa...

Learn More

Boulder biotech company Inscripta names new CEO

The company has been growing over the past several years, and recently went to market with its genomic engineering platform. Learn more in the Denver Business Journal article.

Learn More